With about ten started companies and fifty investments, Krim Talia has a good eye for the industry. Since June, he has been CEO of the accelerator and incubator Sting. In this interview, he shares his thoughts on the future of life science startups, Hagastaden, and what it takes to get more people to invest in their innovation. 

In January 2023, the PANCAID project started – a new chapter in the battle against pancreatic cancer. This international, interdisciplinary research consortium combines oncology, molecular biology, bioinformatics, and clinical research expertise, providing a broad perspective and vast knowledge.